Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

TEMPI: A Reversible Syndrome Following Treatment with Bortezomib

Wilfried A. Schroyens, MD, PhD, Casey L. O'Connell, MD, Martha Q Lacy, MD, Eyal C. Attar, MD, Noopur Raje, MD, Bradley G. Somer, MD, Flavia G Rosado, MD, James Hoyer, MD, Donald I. Feinstein, MD, David B. Sykes, MD, PhD

Blood (2012) 120 (21): 986.

https://doi.org/10.1182/blood.V120.21.986.986

Published: 2012

Journal Articles

A Reassessment of the Red Blood Cell Folate Assay

James Hoyer, MD, Jennifer Oliveira, MD, Nikola Baumann, PhD, Amy Saenger, PhD

Blood (2010) 116 (21): 3209.

https://doi.org/10.1182/blood.V116.21.3209.3209

Published: 2010

Journal Articles

Isolated Trisomy 8 in the Myelodysplastic Syndromes.

Naseema Gangat, MBBS, Patricia Greipp, DO, Curtis A Hanson, MD, James Hoyer, MD, Dong Chen, MD, PhD, Rhett P. Ketterling, MD, David Dingli, M.D., PhD.

Blood (2009) 114 (22): 2785.

https://doi.org/10.1182/blood.V114.22.2785.2785

Published: 2009

Journal Articles

Deletion 5q in AML: A Clinicopathological Description of 79 Cases from a Single Institution

Rafael Santana-Davila, MD, Shernan G. Holtan, MD, Rhett Ketterling, MD, Ryan A Knudson, David P. Steensma, MD, FACP, Dong Chen, MD, PhD, James Hoyer, MD, Curtis A Hanson, MD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 2523.

https://doi.org/10.1182/blood.V112.11.2523.2523

Published: 2008

Journal Articles

Prior Treatment Relates More Strongly to Richter’s Transformation Than ZAP-70, CD38, IgV H Gene Mutation Status, and Cytogenetic Abnormalities: Findings of an Observational Cohort Study of 962 Patients with CLL.

Kami Maddocks-Christianson, Clive S. Zent, MD, Susan Slager, PhD, Susan Schwager, Megan Reinalda, Timothy G. Call, MD, Deborah Bowen, MD, James Hoyer, MD, Diane F. Jelinek, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD

Blood (2006) 108 (11): 2777.

https://doi.org/10.1182/blood.V108.11.2777.2777

Published: 2006

NARROW

TEMPI: A Reversible Syndrome Following Treatment with Bortezomib

A Reassessment of the Red Blood Cell Folate Assay

Isolated Trisomy 8 in the Myelodysplastic Syndromes.

Deletion 5q in AML: A Clinicopathological Description of 79 Cases from a Single Institution

Prior Treatment Relates More Strongly to Richter’s Transformation Than ZAP-70, CD38, IgV H Gene Mutation Status, and Cytogenetic Abnormalities: Findings of an Observational Cohort Study of 962 Patients with CLL.

Email alerts

ASH Publications

American Society of Hematology

TEMPI: A Reversible Syndrome Following Treatment with Bortezomib

A Reassessment of the Red Blood Cell Folate Assay

Isolated Trisomy 8 in the Myelodysplastic Syndromes.

Deletion 5q in AML: A Clinicopathological Description of 79 Cases from a Single Institution

Prior Treatment Relates More Strongly to Richter’s Transformation Than ZAP-70, CD38, IgV H Gene Mutation Status, and Cytogenetic Abnormalities: Findings of an Observational Cohort Study of 962 Patients with CLL.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only